# Baird Type: Company Source: GetYourBrief — https://getyourbrief.com/entity/baird Canonical HTML page: https://getyourbrief.com/entity/baird ## Timeline - **2026-03-23**: Merger Reports — Reports surface regarding potential merger discussions between Estée Lauder and Puig. - **2026-03-14**: Insider Selling — President and another insider report share sales in regulatory filings. - **2026-03-14**: Insider Selling — President and another insider sell a combined 33,157 shares. - **2026-03-10**: Analyst Downgrade — Wall Street Zen cuts ALHC rating to Hold. - **2026-03-10**: Analyst Downgrade — Wall Street Zen cuts ALHC rating to Hold. - **2026-03-09**: Analyst Upgrade — Baird raises Zions Bancorporation to a Buy-equivalent rating. - **2026-03-03**: Offering Priced — Secondary offering is priced at $19.46 per share. - **2026-03-03**: Secondary Offering — Company prices 13.2M shares at $19.46 to raise capital. - **2026-03-02**: Secondary Offering Announced — Company announces intent to sell 13.2 million shares to raise capital. - **2026-03-01**: Expected Q4 Earnings Call — Management is anticipated to provide final 2025 figures and formal guidance for the 2026 fiscal year. - **2026-02-28**: Q4 Earnings Report — Alignment Healthcare reports a declining net loss for the fourth quarter of 2025. - **2026-02-27**: Q4 Earnings Report — Alignment Healthcare reports declining losses and operational growth. - **2026-02-25**: Earnings Preview Release — FinancialContent and other market trackers highlight ALHC as a key stock to watch ahead of Q4 reporting. - **2026-02-24**: Agency Shift — Estée Lauder appoints WPP as its global media agency partner. - **2026-02-23**: M&A Strategy — Estée Lauder CEO expresses openness to strategic acquisitions to aid turnaround. ## Recent coverage (6 stories, network-wide) ### Analyst upgrades drive 13% CarMax rebound as Stephens turns bullish with $66 target 2026-06-20 10:22:09 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 CarMax stock rebounded sharply after analysts issued bullish revisions; Stephens upgraded to buy with a $66 target, Baird raised to $55, and even J.P. Morgan lifted its target slightly. Full story: https://getfinancebrief.com/story/carmax-rebound-analyst-upgrade-finance ### CarMax stock surges 13% as used-car retailer defies tough market with 6% sales growth 2026-06-20 10:21:03 · Sector: retail · Sentiment: Neutral · Impact: 5/10 · Sources: 2 CarMax’s Q1 results beat estimates, but investors sold off initially. Then Stephens upgraded the stock to buy with a $66 target, highlighting its used-car dominance, and shares rebounded sharply. Full story: https://getretailbrief.com/story/carmax-surge-13-percent-retail-analyst-upgrade ### Estée Lauder-Puig Merger Talks and Regional Bank Resilience Lead After-Hours 2026-03-23 22:20:26 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Estée Lauder is reportedly in strategic merger discussions with Spanish beauty giant Puig as part of an aggressive turnaround plan. Meanwhile, Zions Bancorporation and Boreal Carbon Corp are drawing significant investor attention following analyst upgrades and shifting sentiment in environmental markets. Full story: https://getfinancebrief.com/story/estee-lauder-puig-merger-zions-bancorp-after-hours ### Alignment Healthcare Insider Sales Follow $257M Secondary Offering 2026-03-14 03:12:21 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Alignment Healthcare's President and another insider divested over 33,000 shares in mid-March, following a massive secondary offering and a rating downgrade. The sales come as the Medicare Advantage provider reports narrowing losses but faces a shift in analyst sentiment from 'Buy' to 'Hold.' Full story: https://getfinancebrief.com/story/alignment-healthcare-insider-selling-secondary-offering ### Alignment Healthcare Insiders Sell Shares Following $250M Secondary Offering 2026-03-14 03:08:58 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 2 Alignment Healthcare (NASDAQ: ALHC) has reported significant insider selling, including a 29,113-share disposal by its President, shortly after a major secondary offering. These transactions occur as the company navigates a shift in analyst sentiment and a challenging regulatory environment for Medicare Advantage providers. Full story: https://gethealthbrief.com/story/alignment-healthcare-insider-selling-analysis ### Alignment Healthcare Q4 Preview: Tech-Enabled Medicare Advantage in Focus 2026-02-25 05:04:46 · Sector: health · Sentiment: Neutral · Impact: 5/10 · Sources: 8 Alignment Healthcare (ALHC) is set to report its fourth-quarter results, with investors focusing on membership growth and the medical loss ratio (MLR) within its tech-enabled Medicare Advantage platform. As the MA market faces regulatory headwinds, ALHC's ability to maintain clinical outcomes through its proprietary AVA software remains a critical differentiator. Full story: https://gethealthbrief.com/story/alignment-healthcare-q4-earnings-preview-medicare-advantage --- This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.